Modern Rheumatology最新文献

筛选
英文 中文
Development of the Japan College of Rheumatology guidance on musculoskeletal ultrasound scanning protocol in rheumatology practice (revised edition). 制定日本风湿病学会风湿病实践中肌肉骨骼超声扫描协议指南(修订版)。
IF 2.1 4区 医学
Modern Rheumatology Pub Date : 2026-11-04 DOI: 10.1093/mr/roag045
Takehisa Ogura, Kei Ikeda, Shin-Ya Kawashiri, Michihiro Ogasawara, Tadashi Okano, Makoto Wada, Tatsunori Horie, Ryusuke Yoshimi, Ryuichi Nakahara, Ryota Hara, Asami Abe, Masahiro Ayano, Koji Funahashi, Chihiro Imaizumi, Natsuko Nakagawa, Atsushi Kawakami
{"title":"Development of the Japan College of Rheumatology guidance on musculoskeletal ultrasound scanning protocol in rheumatology practice (revised edition).","authors":"Takehisa Ogura, Kei Ikeda, Shin-Ya Kawashiri, Michihiro Ogasawara, Tadashi Okano, Makoto Wada, Tatsunori Horie, Ryusuke Yoshimi, Ryuichi Nakahara, Ryota Hara, Asami Abe, Masahiro Ayano, Koji Funahashi, Chihiro Imaizumi, Natsuko Nakagawa, Atsushi Kawakami","doi":"10.1093/mr/roag045","DOIUrl":"10.1093/mr/roag045","url":null,"abstract":"<p><strong>Objectives: </strong>To describe the methodological framework and consensus-based decision rules that underpin the revised guidance on musculoskeletal ultrasound scanning protocols in rheumatology practice.</p><p><strong>Methods: </strong>A systematic literature search on musculoskeletal ultrasound imaging and assessment methods was conducted to extract candidate anatomical structures and their corresponding scanning techniques from the included articles. A Delphi survey of the Guidance Development Panel selected the sites for inclusion. Iterative consensus meetings defined standardised scanning procedures for each structure, including patient positioning, limb orientation, probe placement, scanning direction, and the key anatomical landmarks to be captured on the ultrasound images.</p><p><strong>Results: </strong>A total of 3168 unique records were identified, of which 36 were included after screening. Based on the included articles and the first edition, a list of 159 candidate anatomical structures across the seven regions was compiled (including two structures added during the consensus process). Through the Delphi process, 50 structures were endorsed for inclusion. An image atlas was produced presenting the standardised views used in routine practice and the scanning procedures for the recommended structures.</p><p><strong>Conclusions: </strong>This revised guidance provides standardised musculoskeletal ultrasound scanning methods for rheumatic diseases based on a systematic literature search and a structured consensus process.</p>","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":"909-917"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147973704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of exercise program applied to patients with scleroderma on functional outcomes: A randomized controlled trial. 硬皮病患者运动计划对功能结局的影响:一项随机对照试验。
IF 2.1 4区 医学
Modern Rheumatology Pub Date : 2026-11-04 DOI: 10.1093/mr/roag052
Gizem Ozbudak, Serap Ozer, Figen Yargucu Zihni
{"title":"The effect of exercise program applied to patients with scleroderma on functional outcomes: A randomized controlled trial.","authors":"Gizem Ozbudak, Serap Ozer, Figen Yargucu Zihni","doi":"10.1093/mr/roag052","DOIUrl":"10.1093/mr/roag052","url":null,"abstract":"<p><strong>Objectives: </strong>The study investigated the effects of an exercise program applied to patients with systemic sclerosis on hand and mouth functional results and quality of life.</p><p><strong>Methods: </strong>This randomized controlled experimental study included 46 patients with systemic sclerosis, divided into an intervention group (n = 23) and control group (n = 23) using simple randomization. Data were collected using Exercise Program Digital Versatile Disc (DVD), Duruöz Hand Scale, Mouth Opening Measurement Form and World Health Organization Quality of Life-BREF (WHOQOL-BREF, brief version). Patients in the intervention group received the exercise program in addition to the standard protocol and the DVD was uploaded to their mobile phones after the initial interview. All patients were assessed at baseline, 4, 8 and 12 weeks.</p><p><strong>Results: </strong>Overall, 95.5% of patients were female, with a mean age of 51.70 ± 11.11 years. Groups were homogeneous in demographic characteristics (P > .05). Statistically significant differences were observed between the intervention and control groups in hand function, mouth function, and quality of life at the final follow-up.</p><p><strong>Conclusion: </strong>In conclusion, the exercise program applied to patients with systemic sclerosis had positive effects on hand and mouth functional outcomes and quality of life, demonstrating its overall effectiveness in improving functional abilities and well-being.</p>","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":"998-1006"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148412299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical pre-training and fine-tuning improve large-language-model prediction of rheumatoid-arthritis disease activity. 医学预训练和微调改进了类风湿关节炎疾病活动的大语言模型预测。
IF 2.1 4区 医学
Modern Rheumatology Pub Date : 2026-11-04 DOI: 10.1093/mr/roag039
Suguru Honda, Katsunori Ikari, Mayuko Fujisaki, Eiichi Tanaka, Masayoshi Harigai
{"title":"Medical pre-training and fine-tuning improve large-language-model prediction of rheumatoid-arthritis disease activity.","authors":"Suguru Honda, Katsunori Ikari, Mayuko Fujisaki, Eiichi Tanaka, Masayoshi Harigai","doi":"10.1093/mr/roag039","DOIUrl":"10.1093/mr/roag039","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate whether medical-domain pre-training and parameter-efficient fine-tuning improve the ability of locally deployable Large Language Models (LLMs) to predict long-term disease activity and disability in rheumatoid arthritis, and to benchmark their performance against established tabular machine-learning models.</p><p><strong>Methods: </strong>We trained on-premises Llama-2 (70B) models with and without medical pre-training (Meditron) and applied Quantized Low-Rank Adapter fine-tuning using structured data from 11 865 patients in the Institute of Rheumatology, Rheumatoid Arthritis cohort. Models predicted eight binary outcomes of rheumatoid arthritis disease activity and disability at 2 years. Performance was compared with logistic regression, random forest, and XGBoost using receiver operating characteristic-area under the curve, Brier score, calibration plots, and decision-curve analysis.</p><p><strong>Results: </strong>Medical pre-training and Quantized Low-Rank Adapter fine-tuning both improved discrimination and calibration, with effects varying by endpoint. Fine-tuned LLMs achieved the highest or comparable receiver operating characteristic-area under the curves for most Disease Activity Score-based outcomes and matched conventional models for remission tasks. In low-prevalence outcomes, LLMs showed more stable calibration and small but consistent net-benefit advantages, while some tabular models exhibited clinically harmful decision curves.</p><p><strong>Conclusions: </strong>Endpoint-specific, privacy-preserving LLMs can complement or replace conventional tabular models for rheumatoid arthritis disease-activity prediction, providing reliable, locally deployable decision support without sacrificing data privacy.</p>","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":"927-934"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147949020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fibromyalgia diagnosis: From past paradigms to future directions-The state of the art and ongoing controversies. 纤维肌痛的诊断:从过去的范式到未来的方向-艺术的状态和正在进行的争议。
IF 2.1 4区 医学
Modern Rheumatology Pub Date : 2026-11-04 DOI: 10.1093/mr/roag055
André Pontes-Silva
{"title":"Fibromyalgia diagnosis: From past paradigms to future directions-The state of the art and ongoing controversies.","authors":"André Pontes-Silva","doi":"10.1093/mr/roag055","DOIUrl":"10.1093/mr/roag055","url":null,"abstract":"<p><p>Fibromyalgia remains a contested clinical entity, characterized by uncertainty regarding its definition, diagnostic boundaries, and underlying mechanisms. Over the past three decades, diagnostic frameworks have evolved from the 1990 American College of Rheumatology classification criteria, based on widespread pain and tender point examination, to symptom-based models emphasizing patient-reported outcomes, such as the 2010 and 2016 American College of Rheumatology criteria. While these developments have improved feasibility and expanded clinical recognition, they have remained confined to biomedical and neuropsychological domains. This narrative review examines the historical evolution, conceptual foundations, and methodological limitations of fibromyalgia diagnostic criteria, integrating evidence from classification systems, including the American College of Rheumatology frameworks and the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION)-American Pain Society Pain Taxonomy. Across these models, fibromyalgia is operationalized through symptom aggregation, with limited incorporation of the social and contextual determinants of health. The analysis highlights epistemological tensions, including diagnostic inflation, the continuum of polysymptomatic distress, and debates regarding disease legitimacy. In response, emerging proposals advocate for a biopsychosocial diagnostic framework that integrates biological, psychological, and social dimensions into the diagnostic core. This review also evaluates alternative dual-framework approaches that separate biological diagnosis from psychosocial severity assessment.</p>","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":"876-891"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148339264","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimal glucocorticoid tapering in anti-synthetase syndrome-associated interstitial lung disease: A multicentre MYKO cohort study. 抗合成酶综合征相关间质性肺病的最佳糖皮质激素减量:一项多中心MYKO队列研究
IF 2.1 4区 医学
Modern Rheumatology Pub Date : 2026-11-04 DOI: 10.1093/mr/roag044
Hirofumi Miyake, Takuya Kotani, Takayasu Suzuka, Shogo Matsuda, Katsumasa Oe, Mahiro Yamamoto, Chifumi Akiyama, Takahiro Seno, Takashi Kida, Tomoya Sagawa, Hironori Inoue, Junya Kitai, Yuki Shimada, Keisuke Hirobe, Kazuma Yoshida, Atsubumi Ogawa, Yuto Nakakubo, Yoichi Nakayama, Yasuhiro Nohda, Tsuneo Sasai, Hideaki Tsuji, Ran Nakashima
{"title":"Optimal glucocorticoid tapering in anti-synthetase syndrome-associated interstitial lung disease: A multicentre MYKO cohort study.","authors":"Hirofumi Miyake, Takuya Kotani, Takayasu Suzuka, Shogo Matsuda, Katsumasa Oe, Mahiro Yamamoto, Chifumi Akiyama, Takahiro Seno, Takashi Kida, Tomoya Sagawa, Hironori Inoue, Junya Kitai, Yuki Shimada, Keisuke Hirobe, Kazuma Yoshida, Atsubumi Ogawa, Yuto Nakakubo, Yoichi Nakayama, Yasuhiro Nohda, Tsuneo Sasai, Hideaki Tsuji, Ran Nakashima","doi":"10.1093/mr/roag044","DOIUrl":"10.1093/mr/roag044","url":null,"abstract":"<p><strong>Objectives: </strong>To explore glucocorticoid tapering targets in patients with acute/subacute anti-synthetase syndrome-associated interstitial lung disease (ASyS-ILD).</p><p><strong>Methods: </strong>We retrospectively analysed 86 patients with newly diagnosed acute/subacute ASyS-ILD from the MYKO cohort. Patients were grouped using prednisolone-equivalent dose thresholds of 15, 12.5, and 10 mg/day at 6 months. Exploratory three-group analyses categorised patients into ≤ 12.5, 12.5-15, and >15 mg/day. Matching weights adjusted for baseline confounders. Cox proportional-hazards models evaluated 5-year all-cause mortality and event-free survival for disease flares and infections requiring hospitalisation. A multivariable logistic regression assessed factors associated with achieving ≤ 15 mg/day at 6 months.</p><p><strong>Results: </strong>In two-group analyses, the ≤ 15 mg/day group had a lower infection risk (hazard ratio 0.18, 95% confidence interval 0.04-0.81), whereas analyses using other thresholds showed no clear differences. In the three-group analyses, patients receiving 12.5-15 mg/day tended to have the lowest flare risk. Female sex was associated with achieving ≤ 15 mg/day at 6 months (odds ratio 3.29, 95% confidence interval 1.09-10.13).</p><p><strong>Conclusions: </strong>Tapering to a prednisolone-equivalent dose of 12.5-15 mg/day at 6 months may represent a reasonable target to balance risks of flares and infections in patients with acute/subacute ASyS-ILD.</p>","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":"1007-1015"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147963824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploratory comparison of diffusion-weighted whole-body imaging with background body signal suppression and 18F-FDG PET/CT for assessing disease activity in large-vessel vasculitis. 带有背景信号抑制的弥散加权全身成像与18F-FDG PET/CT评估大血管炎疾病活动性的探索性比较
IF 2.1 4区 医学
Modern Rheumatology Pub Date : 2026-11-04 DOI: 10.1093/mr/roag037
Yuji Nozaki, Atsuhiro Yamamoto, Daisuke Tomita, Tomoko Hyodo, Hayato Kaida, Kazunari Ishii, Koji Kinoshita
{"title":"Exploratory comparison of diffusion-weighted whole-body imaging with background body signal suppression and 18F-FDG PET/CT for assessing disease activity in large-vessel vasculitis.","authors":"Yuji Nozaki, Atsuhiro Yamamoto, Daisuke Tomita, Tomoko Hyodo, Hayato Kaida, Kazunari Ishii, Koji Kinoshita","doi":"10.1093/mr/roag037","DOIUrl":"10.1093/mr/roag037","url":null,"abstract":"<p><strong>Objectives: </strong>To compare diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) with ^18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) for assessing disease activity in large-vessel vasculitis (LVV), and to evaluate whether segment-level analysis provides complementary information beyond global grading.</p><p><strong>Methods: </strong>We enrolled 25 patients with LVV (Takayasu arteritis [TAK], n = 11; giant cell arteritis [GCA], n = 14). Two blinded readers graded 11 arterial territories (18 segments) on a four-point visual scale for DWIBS and FDG-PET/CT. Global imaging grades were calculated as segment-averaged means. Correlations with serum C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) were assessed.</p><p><strong>Results: </strong>Global mean DWIBS grades correlated significantly with FDG-PET/CT grades (r = 0.72) and with CRP levels (r = 0.53). Territory-level mapping revealed diffuse central aortic involvement in GCA, whereas TAK showed more focal and segment-limited patterns. DWIBS demonstrated lower sensitivity in motion-prone regions but appeared to better reflect clinical activity and more frequently detected subclavian artery involvement in TAK compared with FDG-PET/CT. Residual vascular signals were also observed in some patients classified as being in clinical remission.</p><p><strong>Conclusions: </strong>DWIBS shows good agreement with FDG-PET/CT and provides a radiation- and contrast-free approach for assessing LVV. Global mean grades alone showed limited discriminatory power and may underestimate disease activity in focal or segment-limited involvement. Integrating segment-level imaging findings with clinical and laboratory markers may improve assessment of disease activity. Multicenter validation and longitudinal studies are warranted.</p>","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":"1023-1031"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147856614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidence and radiographic progression of rheumatoid arthritis in anti-citrullinated protein antibody-positive individuals: A 6-year population-based cohort study. 抗瓜氨酸蛋白抗体阳性个体类风湿关节炎的发病率和影像学进展:一项为期6年的基于人群的队列研究。
IF 2.1 4区 医学
Modern Rheumatology Pub Date : 2026-11-04 DOI: 10.1093/mr/roag051
Kenta Makabe, Takumi Matsumoto, Akihiro Uchio, Hiroyasu Mizuhara, Ryutaro Takeda, Toshiko Iidaka, Taro Kasai, Yasunori Omata, Sakae Tanaka, Noriko Yoshimura
{"title":"Incidence and radiographic progression of rheumatoid arthritis in anti-citrullinated protein antibody-positive individuals: A 6-year population-based cohort study.","authors":"Kenta Makabe, Takumi Matsumoto, Akihiro Uchio, Hiroyasu Mizuhara, Ryutaro Takeda, Toshiko Iidaka, Taro Kasai, Yasunori Omata, Sakae Tanaka, Noriko Yoshimura","doi":"10.1093/mr/roag051","DOIUrl":"10.1093/mr/roag051","url":null,"abstract":"<p><strong>Objectives: </strong>Anti-citrullinated protein antibodies (ACPA) predict rheumatoid arthritis (RA) and radiographic joint destruction. However, data on long-term outcomes in ACPA-positive individuals without RA are limited. This study aimed to investigate the 6-year cumulative incidence of RA and radiographic progression among ACPA-positive individuals without RA at baseline in a population-based cohort.</p><p><strong>Method: </strong>A total of 1541 participants without RA at baseline were enrolled from the population-based cohort, of whom 28 tested positive for ACPA. Incident cases of RA were identified based on participants' self-reported physician diagnosis and medication history over a 6-year follow-up period. Radiographic progression in the hands was assessed using the van der Heijde modified Sharp score.</p><p><strong>Results: </strong>Five participants developed RA within the first 3 years, including three who were ACPA-positive at baseline (all with high ACPA titres). After 3 years, additional RA cases were identified only among participants who were ACPA-negative at baseline, whereas no further cases occurred among those who were ACPA-positive at baseline. The positive predictive value of ACPA for RA within 3 years was 15.0%, rising to 30.0% among those with high ACPA titres. When it was combined with the rheumatoid factor or matrix metalloproteinase-3, the positive predictive value further increased. Radiographic progression occurred in all participants with high-titre ACPA who developed RA (n = 3) and in one ACPA-positive individual without RA, but not in ACPA-negative individuals who developed RA.</p><p><strong>Conclusions: </strong>ACPA positivity, particularly at high titres, may be associated with an increased risk of incident RA and with radiographic bone destruction, even in the absence of clinical symptoms or an RA diagnosis.</p>","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":"918-926"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148352406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retraction of: Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis. 撤回:Avacopan,一种选择性C5a受体拮抗剂,用于抗中性粒细胞细胞质抗体相关血管炎。
IF 2.1 4区 医学
Modern Rheumatology Pub Date : 2026-11-04 DOI: 10.1093/mr/roag060
{"title":"Retraction of: Avacopan, a selective C5a receptor antagonist, for anti-neutrophil cytoplasmic antibody-associated vasculitis.","authors":"","doi":"10.1093/mr/roag060","DOIUrl":"10.1093/mr/roag060","url":null,"abstract":"","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":"1066"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148813508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk of 90-day readmission for heart failure among patients with rheumatoid arthritis: A retrospective cohort study. 类风湿关节炎患者因心力衰竭再入院90天的风险:一项回顾性队列研究
IF 2.1 4区 医学
Modern Rheumatology Pub Date : 2026-11-04 DOI: 10.1093/mr/roag040
Takano Toshio, Yamada Keiko, Ishida Ryo, Takeshima Taro
{"title":"Risk of 90-day readmission for heart failure among patients with rheumatoid arthritis: A retrospective cohort study.","authors":"Takano Toshio, Yamada Keiko, Ishida Ryo, Takeshima Taro","doi":"10.1093/mr/roag040","DOIUrl":"10.1093/mr/roag040","url":null,"abstract":"<p><strong>Objectives: </strong>Patients with rheumatoid arthritis (RA) are at an increased risk of developing heart failure (HF); however, the risk of readmission due to HF in patients with RA remains unclear. This study aimed to identify the risk of HF readmission among patients with RA.</p><p><strong>Methods: </strong>We included patients with RA aged ≥18 years who were hospitalized for the first time with HF and discharged between January 2012 and December 2019. The incidence of 90-day HF readmission was assessed. We reported the risk factors for HF readmission using the Fine-Gray model as adjusted subdistribution hazard ratios (aSHRs) and 95% confidence intervals (CIs).</p><p><strong>Results: </strong>The analysis included 1274 patients (mean age, 76.4 years; 61.5% female; mean Charlson Comorbidity Index, 4.6). There were 146 (11.5%) cases of 90-day HF readmission, associated with the Charlson Comorbidity Index (aSHR: 1.08, 95% CI: 1.01-1.15), diuretic use (aSHR: 1.48, 95% CI: 1.03-2.13), and opioid use (aSHR: 1.76, 95% CI: 1.11-2.77).</p><p><strong>Conclusions: </strong>Patients with RA appeared to have a higher incidence of 90-day HF readmission than the general HF registry population. HF readmission was associated with high Charlson Comorbidity Index scores and the use of diuretics and opioids.</p>","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":"935-940"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147949058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High burden of coinfection in systemic lupus erythematosus with bronchoalveolar lavage confirmed Pneumocystis jirovecii pneumonia: A single-centre retrospective study. 系统性红斑狼疮合并支气管肺泡灌洗确诊的乙氏肺囊虫肺炎并发感染的高负担:一项单中心回顾性研究
IF 2.1 4区 医学
Modern Rheumatology Pub Date : 2026-11-04 DOI: 10.1093/mr/roag041
Kai-Chun Wang, Chien-Chih Lai, Wei-Sheng Chen, Hsien-Tzung Liao, Ming-Han Chen, De-Feng Huang, Chang-Youh Tsai, Ling-Ying Lu, Sheng-Jie Yu, Ming-Hong Tai, Yi-Syuan Sun
{"title":"High burden of coinfection in systemic lupus erythematosus with bronchoalveolar lavage confirmed Pneumocystis jirovecii pneumonia: A single-centre retrospective study.","authors":"Kai-Chun Wang, Chien-Chih Lai, Wei-Sheng Chen, Hsien-Tzung Liao, Ming-Han Chen, De-Feng Huang, Chang-Youh Tsai, Ling-Ying Lu, Sheng-Jie Yu, Ming-Hong Tai, Yi-Syuan Sun","doi":"10.1093/mr/roag041","DOIUrl":"10.1093/mr/roag041","url":null,"abstract":"<p><strong>Objectives: </strong>To assess coinfection burden and identify predictors of early mortality in systemic lupus erythematosus (SLE) with bronchoalveolar lavage fluid (BALF)-confirmed Pneumocystis jirovecii pneumonia (PJP).</p><p><strong>Methods: </strong>We retrospectively enrolled SLE patients with BALF-confirmed PJP. Clinical and microbiologic data from BALF and blood were reviewed. Predictors of 1-month mortality were analysed using univariable and multivariable logistic regression, with risk stratification and Kaplan-Meier analyses.</p><p><strong>Results: </strong>Twenty-four SLE patients with BALF-confirmed PJP were identified. BALF coinfection occurred in 15 (62.5%), most commonly cytomegalovirus (54.2%). Among those assessed, cytomegalovirus viremia was present in 55.0% and bacteraemia in 29.2%. The 1-month and in-hospital mortality rates were 37.5 and 62.5%, respectively. Twenty patients (83.3%) required intubation. Given the limited number of events, the multivariable model was considered exploratory; concomitant bacteraemia (P = .008) and glucocorticoid (GC) pulse therapy within 1 month (P = .036) were associated with 1-month mortality. Mortality increased stepwise with 0, 1, and 2 factors (18.8, 66.7, and 100%), and Kaplan-Meier analyses showed shorter survival with either factor.</p><p><strong>Conclusion: </strong>SLE patients with BALF-confirmed PJP have a high coinfection burden and substantial short-term mortality. Bacteraemia and recent GC pulse therapy identify a high-risk clinical context. Timely bronchoscopy supports coinfection detection and guides management.</p>","PeriodicalId":18705,"journal":{"name":"Modern Rheumatology","volume":" ","pages":"979-987"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147949060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书